In:
International Journal of Urology, Wiley, Vol. 31, No. 9 ( 2024-09), p. 1038-1045
Kurzfassung:
To assess the association among preoperative total testosterone levels, postoperative sexual function, and prognosis after robot‐assisted radical prostatectomy. Methods Patients who underwent robot‐assisted radical prostatectomy in our institution were included in the study. Based on preoperative total testosterone levels, they were divided into low ( 〈 3.0 ng/mL) and high (≥3.0 ng/mL) total testosterone groups. Sexual function was evaluated using the International Index of Erectile Function scores, Expanded Prostate Cancer Index Composite scores, and the potency rate from preoperatively to 12 months after surgery. Oncological outcomes were evaluated based on biochemical recurrence. Results Out of 233 patients included, no significant difference in sexual function was found between the high ( n = 183) and the low ( n = 50) total testosterone groups at any point before or after surgery. However, in nerve‐sparing cases, preservation in postoperative sexual function was observed only in the high total testosterone group (International Index of Erectile Function scores and Expanded Prostate Cancer Index Composite sexual function scores, at any point after surgery, p 〈 0.05; potency rate, at 3, 6, and 12 months after surgery; p 〈 0.05). Additionally, the high total testosterone group showed better biochemical recurrence‐free survival than the low total testosterone group ( p = 0.008). Conclusions In the high total testosterone group, preservation in sexual function was observed after the nerve‐sparing procedure, while the biochemical recurrence rate was low. Therefore, patients with high levels of total testosterone may be advised to consider nerve‐sparing interventions.
Materialart:
Online-Ressource
ISSN:
0919-8172
,
1442-2042
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2024
ZDB Id:
2009793-1
Bookmarklink
